Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Buloxibutid for efficacy and safety in idiopathic pulmonary fibrosis. The study is sponsored by Vicore Pharma AB and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Buloxibutid (buloxibutid)

Snippet

Sponsor: Vicore Pharma AB | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Status: ACTIVE_NOT_RECRUITING